Want to join the conversation?
RBC Capital Markets analyst Michael Carroll asks about the sequential improvement in HCR ManorCare, the drivers of occupancy improvement and its sustainability. $HCP CFO Tim Schoen says that there was a seasonally higher census improvement. It had about a 20% increase, up about $21MM in 1Q16 vs. 4Q15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.